Humacyte, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−6.34%
vs ±38.1% implied · ×0.17
shaded = implied · ▲▼ = realized
No thesis.
Humacyte, Inc.
0.42
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Antipodes PartnersAntipodes Partners | $7.9M | 13.31% | +76.52% | |
| 2 | Vanguard Capital ManagementVanguardindex-like | $7.9M | 13.31% | +41.20% | |
| 3 | Alyeska Investment GroupAlyeska Investment | $4.7M | 7.94% | new | |
| 4 | Davidson Kempner Capital ManagementDavidson Kempner | $3.9M | 6.59% | new | |
| 5 | BlackRockBlackRockindex-like | $3.8M | 6.38% | −60.71% | |
| 6 | Great Point PartnersGreat Point Partners | $2.9M | 4.94% | 0.00% | |
| 7 | Susquehanna International GroupSusquehanna International | $2.3M | 3.81% | +64.44% | |
| 8 | UBS GroupUBS | $2.2M | 3.75% | +2.21% | |
| 9 | AQR Capital ManagementAQR | $2.0M | 3.42% | +34.94% | |
| 10 | Geode Capital ManagementGeodeindex-like | $1.7M | 2.88% | −40.26% | |
| 11 | Millennium ManagementMillennium | $1.5M | 2.52% | +1665.12% | |
| 12 | Citadel AdvisorsCitadel | $1.5M | 2.46% | +371.99% | |
| 13 | Charles Schwab Investment ManagementCharles Schwabindex-like | $1.1M | 1.78% | +4.81% | |
| 14 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $921,395 | 1.56% | +16.84% | |
| 15 | HRT FinancialHRT Financial | $850,000 | 1.44% | new | |
| 16 | LPL FinancialLPL Financial | $800,327 | 1.35% | +18.63% | |
| 17 | GSA Capital PartnersGSA Capital Partners | $785,000 | 1.33% | +302.52% | |
| 18 | Private Advisor GroupPrivate Advisor | $753,156 | 1.27% | +15.89% | |
| 19 | State StreetState Streetindex-like | $657,516 | 1.11% | −72.32% | |
| 20 | HBK Investments L PHBK Investments L P | $616,516 | 1.04% | new | |
| 21 | Wealth EffectsWealth Effects | $541,535 | 0.91% | +239.33% | |
| 22 | Lion Point CapitalLion Point Capital | $507,260 | 0.86% | 0.00% | |
| 23 | LuminArx Capital ManagementLuminArx | $507,260 | 0.86% | new | |
| 24 | Goldman Sachs GroupGoldman Sachs | $457,723 | 0.77% | −13.37% | |
| 25 | Bank of AmericaBank of America | $451,303 | 0.76% | +46.07% |
167 managers report $59.2M of Humacyte on form 13F for the quarter ended Jun 30 '26. 18 of them hold 80% of it; Antipodes Partners is largest at 13.31%.
Linked news
Expected move
No implied move.
No implied move.
No implied move.